GenVec Company Profile (NASDAQ:GNVC)

About GenVec

GenVec logoGenVec, Inc. (GenVec) is a clinical-stage biopharmaceutical company, engaged in the development of therapeutics and vaccines. The Company designs, tests and manufactures adenoviral-based product candidates. The Company's development programs address therapeutic areas, such as hearing loss and balance disorders, as well as vaccines against infectious diseases, including respiratory syncytial virus (RSV), herpes simplex virus (HSV), Enterovirus D68 (EV-D68) and malaria. In the area of animal health, it is developing vaccines against foot-and-mouth disease (FMD). The Company develops and commercializes its product candidates through collaborations. The Company's lead product candidate is CGF166. The Company's vaccine candidates include preventative vaccines against RSV and malaria, and a therapeutic vaccine for HSV. The Company is developing vaccine and anti-viral candidates for the prevention and containment of FMD outbreaks.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GNVC
  • CUSIP:
Key Metrics:
  • Previous Close: $6.61
  • 50 Day Moving Average: $6.28
  • 200 Day Moving Average: $2.37
  • 52-Week Range: $2.70 - $14.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.35
  • P/E Growth: 0.00
  • Market Cap: $14.96M
  • Outstanding Shares: 2,273,000
  • Beta: 3.14
Profitability:
  • Net Margins: -909.71%
  • Return on Equity: -88.05%
  • Return on Assets: -64.04%
Debt:
  • Current Ratio: 6.00%
  • Quick Ratio: 6.00%
Additional Links:
Companies Related to GenVec:

Analyst Ratings

Consensus Ratings for GenVec (NASDAQ:GNVC) (?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $11.33 (72.24% upside)

Analysts' Ratings History for GenVec (NASDAQ:GNVC)
Show:
DateFirmActionRatingPrice TargetDetails
1/25/2017HC WainwrightDowngradeHold$7.00View Rating Details
1/25/2017Rodman & RenshawDowngradeBuy -> Neutral$15.00 -> $7.00View Rating Details
7/26/2016Roth CapitalReiterated RatingBuy$80.00 -> $20.00View Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for GenVec (NASDAQ:GNVC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/7/2017        
8/5/2016Q116($0.10)($0.06)ViewN/AView Earnings Details
5/12/2016($0.09)($0.11)ViewN/AView Earnings Details
3/9/2016Q415($0.08)($0.10)ViewN/AView Earnings Details
8/7/2015Q215($0.10)($0.11)ViewN/AView Earnings Details
5/8/2015Q115($0.06)($0.09)ViewN/AView Earnings Details
3/24/2015Q414$0.08$0.11$3.33 million$3.50 millionViewListenView Earnings Details
11/12/2014Q314($0.11)($0.10)ViewN/AView Earnings Details
8/12/2014Q214($0.15)($0.10)ViewN/AView Earnings Details
5/12/2014Q114$0.04($0.07)$2.00 million$2.10 millionViewN/AView Earnings Details
3/28/2014Q413($0.16)($0.07)$1.52 million$0.15 millionViewListenView Earnings Details
11/12/2013Q313($0.23)$2.10 million$1.60 millionViewN/AView Earnings Details
11/9/2012Q312($0.32)($0.30)$2.90 million$2.13 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for GenVec (NASDAQ:GNVC)
Current Year EPS Consensus Estimate: $-2.50 EPS
Next Year EPS Consensus Estimate: $-2.80 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.09)($0.09)($0.09)
Q3 20161($0.09)($0.09)($0.09)
Q4 20161($0.09)($0.09)($0.09)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for GenVec (NASDAQ:GNVC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for GenVec (NASDAQ:GNVC)
Insider Ownership Percentage: 8.10%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/16/2016Douglas J SwirskyCEOBuy10,000$0.50$5,000.00View SEC Filing  
12/14/2015Douglas J SwirskyCEOBuy5,000$2.00$10,000.00View SEC Filing  
11/16/2015Stefan LorenDirectorBuy4,000$1.93$7,720.00View SEC Filing  
8/11/2015Douglas E BroughInsiderBuy4,600$2.34$10,764.00View SEC Filing  
5/27/2014Ecor1 Capital, LlcMajor ShareholderBuy24,140$2.24$54,073.60View SEC Filing  
3/28/2014Ecor1 Capital, LlcMajor ShareholderBuy122,273$2.55$311,796.15View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for GenVec (NASDAQ:GNVC)
DateHeadline
News IconAre Insiders Buying This Stock? GenVec, Inc. (NASDAQ:GNVC ... - Winfield Review (NASDAQ:GNVC)
winfieldreview.com - February 20 at 5:01 PM
News IconHere's Who Just Picked Up Genvec Inc. (NASDAQ:GNVC) Shares - Small Cap Exclusive (press release) (NASDAQ:GNVC)
smallcapexclusive.com - February 18 at 12:23 PM
prnewswire.com logoWeissLaw LLP: GenVec, Inc. Acquisition May Not Be in the Best Interests of GNVC Shareholders - PR Newswire (press release) (NASDAQ:GNVC)
www.prnewswire.com - February 8 at 11:04 PM
finance.yahoo.com logoWeissLaw LLP: GenVec, Inc. Acquisition May Not Be in the Best Interests of GNVC Shareholders (NASDAQ:GNVC)
finance.yahoo.com - February 8 at 11:04 PM
finance.yahoo.com logoINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of GenVec, Inc. And Encourages Investors To Contact The Firm For Additional Information (NASDAQ:GNVC)
finance.yahoo.com - February 6 at 5:33 PM
finance.yahoo.com logoGENVEC INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of GenVec, Inc. (NASDAQ:GNVC)
finance.yahoo.com - February 2 at 6:04 PM
News IconAre Insiders Bumping Up Their Positions in GenVec, Inc. (NASDAQ:GNVC) - Wall Street Beacon (NASDAQ:GNVC)
wsbeacon.com - January 30 at 11:12 PM
News IconInvestor Technical Review for GenVec Inc. (GNVC) - Rives Journal (NASDAQ:GNVC)
rivesjournal.com - January 28 at 5:37 PM
News IconWhat Are the Technicals Saying About These Shares: GenVec Inc. (GNVC) - Sherwood Daily (NASDAQ:GNVC)
sherwooddaily.com - January 26 at 6:57 PM
News IconStock Seesawing as Volatility Sweeps in on GenVec, Inc. (NASDAQ:GNVC) - Wall Street Beacon (NASDAQ:GNVC)
wsbeacon.com - January 26 at 6:57 PM
streetinsider.com logoRodman & Renshaw Downgrades GenVec, Inc. (GNVC) to Neutral - StreetInsider.com (NASDAQ:GNVC)
www.streetinsider.com - January 26 at 6:57 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of GenVec, Inc. to Intrexon Corporation is Fair to Shareholders - GNVC (NASDAQ:GNVC)
finance.yahoo.com - January 26 at 6:56 PM
News IconIntrexon to Acquire GenVec (NASDAQ:GNVC)
pipelinereview.com - January 25 at 9:52 PM
investopedia.com logoIntrexon To Buy GenVec For $7 a Share (XON, GNVC) (NASDAQ:GNVC)
www.investopedia.com - January 25 at 4:51 PM
finance.yahoo.com logoGenVec downgraded by Rodman & Renshaw (NASDAQ:GNVC)
finance.yahoo.com - January 25 at 4:51 PM
investopedia.com logoIntrexon To Buy GenVec In Stock Deal For $7/Shr (NASDAQ:GNVC)
www.investopedia.com - January 25 at 4:51 PM
rttnews.com logoGenVec Inc. (GNVC) Is Up Sharply After Bought By Intrexon (NASDAQ:GNVC)
www.rttnews.com - January 24 at 6:14 PM
biz.yahoo.com logoGENVEC INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rights of Securit (NASDAQ:GNVC)
biz.yahoo.com - January 24 at 6:14 PM
News IconPriming The Pump: Stock Volatility Spotted in GenVec, Inc. (NASDAQ:GNVC) - Wall Street Beacon (NASDAQ:GNVC)
wsbeacon.com - January 23 at 10:55 PM
News IconAre Insiders Filling Their Own Pockets With Shares? Insider Update on GenVec, Inc. (NASDAQ:GNVC) - Wall Street Beacon (NASDAQ:GNVC)
wsbeacon.com - January 23 at 5:53 PM
News IconTraders are Keeping Track of Technicals on Shares of GenVec Inc. (GNVC) - Sherwood Daily (NASDAQ:GNVC)
sherwooddaily.com - January 22 at 5:24 PM
News IconStock at the Top of the Heap, Pulling in Gains For Investors: GenVec, Inc. (NASDAQ:GNVC) - Aiken Advocate (NASDAQ:GNVC)
aikenadvocate.com - January 20 at 6:49 PM
News IconTechnical Trading: Focus on Shares of GenVec Inc. (GNVC) - Rives Journal (NASDAQ:GNVC)
rivesjournal.com - January 20 at 6:49 PM
News IconTrading Review: Technical Survey on Shares of GenVec Inc. (GNVC) - Sherwood Daily (NASDAQ:GNVC)
sherwooddaily.com - January 20 at 12:18 AM
News IconAmplified Volatility Spotted in Shares of GenVec, Inc. (NASDAQ:GNVC) - Wall Street Beacon (NASDAQ:GNVC)
wsbeacon.com - January 20 at 12:18 AM
News IconTop Biotech Industry, Cancer Treatment Companies (NASDAQ:GNVC)
www.usfinancialnewstoday.com - January 18 at 10:56 PM
News IconInvestors Priming the Pump as Stock Reaches Most Volatile List: GenVec, Inc. (NASDAQ:GNVC) - Wall Street Beacon (NASDAQ:GNVC)
wsbeacon.com - January 17 at 3:28 PM
News IconTracking Corporate Insiders: What Are They Doing With GenVec, Inc. (NASDAQ:GNVC) - Wall Street Beacon (NASDAQ:GNVC)
wsbeacon.com - January 17 at 3:28 PM
News IconGrowth Story Unfolding for GenVec, Inc. (NASDAQ:GNVC) - Prospect Journal (NASDAQ:GNVC)
prospectjournal.com - January 16 at 5:32 PM
News IconPossible breakout plays to watch next week (NASDAQ:GNVC)
ac-investor.blogspot.com - January 15 at 5:13 PM
News IconMarkets End Mostly Higher, How Did This Stock Fare: GenVec, Inc. (NASDAQ:GNVC) - Wall Street Beacon (NASDAQ:GNVC)
wsbeacon.com - January 14 at 5:30 PM
News IconGenVec Inc GNVC Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:GNVC)
www.bioportfolio.com - January 13 at 11:31 PM
News IconStock Getting Tripped Up In Session: GenVec, Inc. (NASDAQ:GNVC) - Wall Street Beacon (NASDAQ:GNVC)
wsbeacon.com - January 12 at 4:06 AM
News IconStock Reaching Most Volatile List Today: GenVec, Inc. (NASDAQ:GNVC) - Wall Street Beacon (NASDAQ:GNVC)
wsbeacon.com - January 12 at 4:06 AM
News IconGenVec, Inc. (Nasdaq: GNVC) Posts Big Gains - StockNewsUnion (NASDAQ:GNVC)
stocknewsunion.com - January 12 at 4:06 AM
smarteranalyst.com logoA Glimpse into 2 Skyrocketing Stocks Today: EnteroMedics Inc (ETRM) and GenVec Inc (GNVC) - Smarter Analyst (NASDAQ:GNVC)
www.smarteranalyst.com - January 12 at 4:06 AM
investing.com logoU.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.16% (NASDAQ:GNVC)
www.investing.com - January 10 at 6:27 PM
smarteranalyst.com logoA Glimpse into 2 Skyrocketing Stocks Today: EnteroMedics Inc (ETRM) and GenVec Inc (GNVC) (NASDAQ:GNVC)
www.smarteranalyst.com - January 10 at 6:27 PM
finance.yahoo.com logoEnteroMedics and GenVec Post Substantial Gains as the NASDAQ is Pushed to Record High (NASDAQ:GNVC)
finance.yahoo.com - January 10 at 6:27 PM
bizjournals.com logoEast Coast biotech company licenses Washington U technology (NASDAQ:GNVC)
www.bizjournals.com - January 9 at 4:18 PM
publicnow.com logoGenVec Signs Option Agreement for Gene Editing and Cell Targeting Technology from Washington University in St. Louis (NASDAQ:GNVC)
us.rd.yahoo.com - January 5 at 6:28 PM
us.rd.yahoo.com logo8:12 am GenVec enters into an exclusive option agreement with Washington University in St. Louis to license intellectual property and technology related to gene editing and pulmonary endothelial cell targeting (NASDAQ:GNVC)
us.rd.yahoo.com - January 5 at 6:28 PM
investornewswire.com logoGenVec, Inc. (NASDAQ:GNVC) Strong Buy Recommendations At 1 - Investor Newswire (NASDAQ:GNVC)
www.investornewswire.com - December 29 at 5:37 PM
realistinvestor.com logoGenVec, Inc. (NASDAQ:GNVC) EPS Prediction At $-0.64 - RealistInvestor.com (NASDAQ:GNVC)
www.realistinvestor.com - December 21 at 6:24 PM
News IconTrading Sheet: Tracking Technicals for GenVec Inc. (GNVC) - Yankee Analysts (NASDAQ:GNVC)
yankeeanalysts.com - December 21 at 6:24 PM
News IconShares to Watch: Indicator Update on GenVec Inc. (GNVC) - Yankee Analysts (NASDAQ:GNVC)
yankeeanalysts.com - December 17 at 10:49 PM
News IconUpside Alert: Delving into Shares of GenVec, Inc. (NASDAQ:GNVC) - Prospect Journal (NASDAQ:GNVC)
prospectjournal.com - December 13 at 9:32 PM
News IconTechnical Investor Update on Shares of GenVec Inc. (GNVC) - Yankee Analysts (NASDAQ:GNVC)
yankeeanalysts.com - December 9 at 5:43 PM
realistinvestor.com logoGenVec, Inc. (NASDAQ:GNVC) Is Expected To Post EPS Of $-0.64 - RealistInvestor.com (NASDAQ:GNVC)
www.realistinvestor.com - December 8 at 11:01 AM
News IconShares Surging Higher, Hitting Winner's List Mid-Session: GenVec, Inc. (NASDAQ:GNVC) - Prospect Journal (NASDAQ:GNVC)
prospectjournal.com - December 6 at 10:40 PM

Social

What is GenVec's stock symbol?

GenVec trades on the NASDAQ under the ticker symbol "GNVC."

When did GenVec's stock split? How did GenVec's stock split work?

GenVec's stock reverse split on Thursday, December 1st 2016. The 1-10 reverse split was announced on Wednesday, November 16th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 30th 2016. An investor that had 100 shares of GenVec stock prior to the reverse split would have 10 shares after the split.

Where is GenVec's stock going? Where will GenVec's stock price be in 2017?

3 brokers have issued twelve-month price objectives for GenVec's shares. Their forecasts range from $7.00 to $20.00. On average, they anticipate GenVec's stock price to reach $11.33 in the next twelve months.

When will GenVec announce their earnings?

GenVec is scheduled to release their next quarterly earnings announcement on Tuesday, March, 7th 2017.

Who owns GenVec stock?

GenVec's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Perceptive Advisors LLC (2.47%). Company insiders that own GenVec stock include Douglas E Brough, Douglas J Swirsky and Stefan Loren.

Who bought GenVec stock? Who is buying GenVec stock?

GenVec's stock was acquired by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC. Company insiders that have bought GenVec stock in the last two years include Douglas E Brough, Douglas J Swirsky and Stefan Loren.

How do I buy GenVec stock?

Shares of GenVec can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of GenVec stock cost?

One share of GenVec stock can currently be purchased for approximately $6.58.

GenVec (NASDAQ:GNVC) Chart for Saturday, February, 25, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for GenVec (NASDAQ:GNVC)

Earnings History Chart

Earnings by Quarter for GenVec (NASDAQ:GNVC)

Dividend History Chart

Dividend Payments by Quarter for GenVec (NASDAQ:GNVC)

Last Updated on 2/25/2017 by MarketBeat.com Staff